Publications by authors named "F Kurnaz"
Article Synopsis
- Glofitamab is a bi-specific antibody used to treat relapsed or refractory B-cell lymphoma, showing potential in a phase II trial, but real-world data is limited.
- A retrospective study in Turkey analyzed 43 DLBCL patients receiving glofitamab, revealing median overall survival of 8.8 months and a 1-year progression-free survival rate of 83%.
- While the treatment had promising effectiveness, toxicity was a significant concern, with deaths linked to disease progression and treatment-related side effects like cytokine release syndrome.
Purpose: Relapse of leukemia relapsing after allogeneic (allo) stem cell transplantation (SCT) remains an important problem. Cytoreductive chemotherapy followed by donor leukocyte infusion (DLI) is one of the treatment modalities in relapsed patients. The current study evaluated the factors affecting overall survival (OS) in allo-SCT patients who received DLI after the first relapse.
View Article and Find Full Text PDFThe aim of the present study was to define the possible association between blood parameters and hair iron concentration in patient groups showing a difference in body iron content. The study population comprised subjects with iron deficiency anaemia and transfusion-related anaemia with different body iron contents and a healthy control group. All the cases included in the study were examined with respect to hair iron concentration, serum iron, total iron-binding capacity (TIBC), transferrin saturation and erythrocyte markers in the total blood count with ferritin values.
View Article and Find Full Text PDFAutologous hematopoietic stem cell transplantation (HSCT) is an important and often life saving treatment for many hematological malignancies and selected solid tumors. To rescue hematopoiesis after high-dose chemotherapy in autologous HSCT depends on maintaining sufficient stem cells. Hematopoietic stem cells and progenitor cells expressing CD34 in the BM are mobilized into the circulation with granulocyte-colony stimulating factor ± chemotherapy prior to autologous HSCT.
View Article and Find Full Text PDFBackground And Aim: Resistive index (RI) is an indirect measurement of blood flow resistance that can be used to evaluate vascular damage in ophthalmologic disease. The purpose of this study was to evaluate the association between RI values of orbital arteries using the color Doppler imaging (CDI) in geriatric hypertensive patients with or without retinopathy.
Setting And Design: Designed as a cross-sectional study.